GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » American Cryostem Corp (OTCPK:CRYO) » Definitions » Market Cap

American Cryostem (American Cryostem) Market Cap : $0.00 Mil (As of Apr. 27, 2024)


View and export this data going back to 2010. Start your Free Trial

What is American Cryostem Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). American Cryostem's share price for the quarter that ended in Jun. 2022 was $0.31005. American Cryostem's Shares Outstanding (EOP) for the quarter that ended in Jun. 2022 was 44.18 Mil. Therefore, American Cryostem's market cap for the quarter that ended in Jun. 2022 was $13.70 Mil.

American Cryostem's quarterly market cap declined from Dec. 2021 ($30.47 Mil) to Mar. 2022 ($18.78 Mil) and declined from Mar. 2022 ($18.78 Mil) to Jun. 2022 ($13.70 Mil).

American Cryostem's annual market cap increased from Sep. 2019 ($17.78 Mil) to Sep. 2020 ($21.74 Mil) but then declined from Sep. 2020 ($21.74 Mil) to Sep. 2021 ($18.41 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. American Cryostem's Enterprise Value for Today is $1.17 Mil.


American Cryostem Market Cap Historical Data

The historical data trend for American Cryostem's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

American Cryostem Market Cap Chart

American Cryostem Annual Data
Trend Sep12 Sep13 Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 45.15 35.67 17.78 21.74 18.41

American Cryostem Quarterly Data
Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.06 18.41 30.47 18.78 13.70

Competitive Comparison of American Cryostem's Market Cap

For the Biotechnology subindustry, American Cryostem's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


American Cryostem's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, American Cryostem's Market Cap distribution charts can be found below:

* The bar in red indicates where American Cryostem's Market Cap falls into.



American Cryostem Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

American Cryostem's Market Cap for the fiscal year that ended in Sep. 2021 is calculated as

Market Cap (A: Sep. 2021 )=Share Price (A: Sep. 2021 )*Shares Outstanding (EOP) (A: Sep. 2021 )
=$0.3*61.3745
=$18.41

American Cryostem's Market Cap for the quarter that ended in Jun. 2022 is calculated as

Market Cap (Q: Jun. 2022 )=Share Price (Q: Jun. 2022 )*Shares Outstanding (EOP) (Q: Jun. 2022 )
=$0.31005*44.1819
=$13.70

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


American Cryostem  (OTCPK:CRYO) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


American Cryostem Market Cap Related Terms

Thank you for viewing the detailed overview of American Cryostem's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


American Cryostem (American Cryostem) Business Description

Traded in Other Exchanges
N/A
Address
1 Meridian Road, Suite 5, Eatontown, NJ, USA, 07724
American Cryostem Corp is a biotechnology company which standardizes adipose tissue-derived technologies (Adult Stem Cells) for the fields of Regenerative and Personalized Medicine. The company acts as an innovator of adipose tissue and stem cell platform technologies. It provides the clinical grade, adipose tissue and adult stem cell collection, processing, and cryo-preservation technology, providing first-in-class cellular therapy products and services for patients, physicians and researchers based on the transformative science of Regenerative and Personalized Medicine.
Executives
John S Arnone director, officer: Chairman 111 GREAT NECK RD, GREAT NECK NY 11021
Anthony Francis Dudzinski director, officer: COO 188 EAST BERGEN PLACE, SUITE 204, RED BANK NJ 07701
Acs Global, Inc. 10 percent owner 188 E. BERGEN PLACE, SUITE 204, RED BANK NJ 07701
Christopher Joseph Neill 10 percent owner 188 EAST BERGEN PLACE, SUITE 204, RED BANK NJ 07701
Hector Medina director, 10 percent owner, officer: President and Director 1206 STAGECOACH TRAIL LOOP, CHULA VISTA CA 91915